ST
ARRY

Spot Trading’s Array Biopharma Inc ARRY Stock Holding History

Spot Trading’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$502K Buy
40,800
+27,000
+196% +$251K 0.01% 1649
2017
Q2 		$116K Buy
13,800
+5,300
+62% +$43.3K ﹤0.01% 2523
2017
Q1 		$76K Buy
+8,500
New +$90.4K ﹤0.01% 2370
2016
Q2 		– Sell
-255,600
Closed -$754K – 4026
2016
Q1 		$754K Buy
255,600
+205,600
+411% +$616K 0.01% 1281
2015
Q4 		$211K Buy
+50,000
New +$228K ﹤0.01% 2439
2014
Q3 		– Sell
-57,000
Closed -$260K – 4906
2014
Q2 		$260K Buy
+57,000
New +$236K ﹤0.01% 3156

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Spot Trading's ARRY Position: Q3 2017 in Review

Spot Trading sold out of Array Biopharma Inc (ARRY) in Q3 2017, closing a stake of 5,598 shares — an estimated $52K sold.

Spot Trading first reported a position in ARRY in Q2 2014 and held it in 5 quarters. The position peaked at $111K in Q1 2015. 184 funds tracked by Wall St. Rank hold ARRY as of Q3 2017.

  • Spot Trading reported no remaining Array Biopharma Inc position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 5,598 Array Biopharma Inc shares in Q3 2017, an estimated $52K.
  • Spot Trading first reported a position in Array Biopharma Inc in Q2 2014 and held it in 5 quarters.
  • Spot Trading's Array Biopharma Inc position peaked at $111K in Q1 2015.
  • 184 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.